Tandem Diabetes Care TNDM Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 54.9%+1.1pp | 53.8%+0.6pp | 53.2%+0.7pp | 52.5%+0.3pp | 52.2%+0.2pp | |
| Operating margin | -8.2%+10.3pp | -18.5%+1.0pp | -19.5%+0.4pp | -19.9%-1.8pp | -18.1%-7.6pp | |
| Net margin | -9.2%+11.0pp | -20.2%0.0pp | -20.2%+0.3pp | -20.5%-1.8pp | -18.7%-8.5pp | |
| Returns | ||||||
| Return on equity | -65.7%+32.2pp | -97.9%+11.8pp | -109.7%+2.2pp | -111.9%-19.6pp | -92.3%-59.0pp | |
| Return on invested capital | -13.1%+17.7pp | -30.8%+2.0pp | -32.8%-0.2pp | -32.6%+6.6pp | -39.2%-24.9pp | |
| Efficiency | ||||||
| Asset turnover | 1×-0.1× | 1.1×0.0× | 1.1×0.0× | 1.1×0.0× | 1.1×+0.1× | |
| Liquidity | ||||||
| Current ratio | 3.6×+1.0× | 2.5×+0.1× | 2.4×0.0× | 2.4×+0.1× | 2.3×-0.6× | |
| Leverage | ||||||
| Debt-to-equity | 5.5×+2.7× | 2.9×-0.5× | 3.4×0.0× | 3.4×+0.2× | 3.2×+1.2× | |
| Per Share | ||||||
| Book value per share | $1.94-15.1% | $2.28+16.1% | $1.97-1.1% | $1.99-15.0% | $2.34-41.2% | |
| Valuation | ||||||
| Market capitalization | $1.03B-23.6% | $1.49B+81.7% | $820.29M-39.0% | $1.34B+5.5% | $1.27B-46.2% | |
| Price / sales | 1×-0.4× | 1.5×+0.7× | 0.8×-0.5× | 1.3×0.0× | 1.3×-1.2× | |
| Price / book | 7.8×-0.9× | 9.6×+3.4× | 6.2×-3.9× | 10.1×+1.9× | 8.2×-0.8× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Tandem Diabetes Care's profit margins?
- Tandem Diabetes Care (TNDM) runs a 54.9% gross margin and a -8.2% operating margin, with a -9.2% net margin.
- Where do Tandem Diabetes Care's ratios come from?
- Every ratio is computed from Tandem Diabetes Care's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
